跳至主要内容
临床试验/CTRI/2012/07/002842
CTRI/2012/07/002842尚未招募未知

A randomized, open label, multi-Centre study to evaluate the outcome of peritonitis with switchFrom glucose based dialysate to icodextrin during an episode of peritonitis.

one0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
one
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Signed informed consent.
  • 2. Men or women above 18 years of age.

排除标准

  • 1. Subject with history of peritonitis within last 1 month.
  • 2. Subject with history of hepatitis B, C or HIV.
  • 3. Subject on immunosuppressant drugs.

研究者

发起方
one

相似试验

已完成
3 期
A clinical trial to study the effects of Darbepoetin alfa in the treatment of anemia caused by chronic kidney disease.
CTRI/2012/07/002835Hetero Drugs Limited236
进行中(未招募)
不适用
A randomized, open-label, multi-center study to evaluate the efficacy of nilotinib versus best supportive care with or without a tyrosine kinase inhibitor (investigator´s choice) in adult patients with gastrointestinal stromal tumors resistant to both imatinib and sunitinibGastrointestinal stromal tumors (GIST)
EUCTR2006-002267-11-DEovartis Pharma Services AG237
已完成
3 期
A randomized, open-label, multi-center study to evaluate the efficacy of nilotinib versus best supportive care with or without a tyrosine kinase inhibitor (investigator's choice) in adult patients with gastrointestinal stromal tumors resistant to both imatinib and sunitinib.10017991GIST
NL-OMON30672ovartis10
进行中(未招募)
不适用
A randomized, open-label, multi-center study to evaluate the efficacy of nilotinib versus imatinib in adult patients with gastrointestinal stromal tumors resistant to imatinib and resistant/intolerant to sunitinib - NDGastrointestinal stromal tumors (GIST)MedDRA version: 9.1Level: LLTClassification code 10051066Term: Gastrointestinal stromal tumour
EUCTR2006-002267-11-ITOVARTIS FARMA210
招募中
3 期
A clinical trial to study the effects of two drugs Peg G-CSF and Grafeel® in the prevention of reduction in neutrophil counts in cancer patients caused by drugs used to treat cancer.
CTRI/2009/091/000694DR.REDDY'S LABORATORIES LTD.Biologics Development Centre , Survey No.47, Bachupalli, Qutubullapur, Hyderabad-500090, A.P, IndiaFax: +91-40-44644507, 91-40-23041418150